FY26 Annual Report and 45th AGM; 99 percent Capital Cut Proposed

Results View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.9%Reaction day

₹10.16

prior close

₹10.66

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.6%+5.5% vs market

Other Textile Products peers, median of 185sector-0.7%+5.6% vs sector

On the reaction day the stock moved 5.5 pts more than Nifty Microcap 250 and 5.6 pts more than its Other Textile Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.9-0.6+5.5-0.7+5.6

Next day

+10.1-0.1+10.2-0.2+10.3

+15.6+0.2+15.4+0.0+15.6

+21.3+0.4+20.8-0.5+21.8

+27.3+0.0+27.3-0.3+27.5

+33.6+0.6+33.0-0.5+34.1

+47.1+0.7+46.5+0.3+46.8

15d

+65.0+1.5+63.5-0.6+65.5

+43.6+0.2+43.4-1.7+45.3

-16.0-3.7-12.3-4.1-12.0

—————

UpDownMarket · Nifty Microcap 250Sector · Other Textile Products peers, median of 185Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Oxford Industries filed its Annual Report for FY26 and notice of 45th AGM on September 11, 2026. Key resolutions include a 99 percent reduction in paid-up equity capital (from Rs. 5.94 crore to Rs. 5.94 lakh) to write off accumulated losses of Rs. 12.95 crore. Also proposed: diversification into healthcare and pharma, shift of registered office from Maharashtra to Odisha, and appointment of new auditor M/s Lipika and Associates.

Likely market impact

Shareholders face near-total dilution from 99 percent capital cut wiping out Rs. 12.95 crore losses. Company pivots into healthcare and pharma business.